Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on September 30, 2022.
May 25, 2023 at 07:30 am
Share
From January 1, 2023 to March 31, 2023, the company has repurchased 23,366 shares, representing 0.46% for KRW 465.05 million. With this, the company has completed the repurchase of 153,589 shares, representing 2.94% for KRW 2,999.38 million under the buyback announced on September 30, 2022.
HLscience Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of healthcare products. The company manufactures products in the areas of live health, climacteric women health, stomach health, antioxidant/skin health, immunity, blood circulation improvement, eye health, intestinal health, articulation health, fatigue/stamina, diet, antioxidant/immunity, multi-vitamin/mineral/calcium, male health and general foods. The Company distributes its productions within domestic market and to overseas markets.
HLSCIENCE CO., LTD. 
